<DOC>
	<DOCNO>NCT01617941</DOCNO>
	<brief_summary>It provide first evaluation efficacy , safety tolerability BGG492 patient non-chronic migraine 3 less 12 migraine attack per 4 week .</brief_summary>
	<brief_title>A Randomized , Double Blind , Placebo Controlled Study Assess Efficacy , Safety Tolerability BGG492 Migraine Prevention</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Male female smoke nonsmoking subject 18 65 year age ( inclusive ) Patients diagnose nonchronic migraine without aura duration least 12 month prior study start Patient diagnose migraine ( accord International Headache Society categories 1.1 equal to/more 3 equal to/ le 12 migraine attack per 4 week last 6 month precede Screening Patients willing abstain activity require focused attention , e.g . drive car vehicle , operate machine engage potentially dangerous activity require focused attention intact physical balance Patients diagnose basilar , ophthalmoplegic hemiplegic migraine show current/past medical history . Patients experience nonmigraine headache 6 day per 4 week past 6 month prior study start Patients receive regular treatment four ( 4 ) week precede Baseline psychoactive drug ( e.g . hypnotic , benzodiazepine , neuroleptic ) except antidepressant ( eg . SSRIs , SNRIs , Tri Tetracyclics ) . Patients receive migraine prevention medication past three ( 3 ) month precede Baseline Patients receive topiramate migraine prevention medication past six ( 6 ) month precede Baseline Patients receive metamizole acute treatment migraine past three ( 3 ) month precede Baseline Patients use ( use within four ( 4 ) week treatment start ) drug treatment potent inhibitor OATP transporter ( e.g . rifampin ) . Any psychiatric condition ( e.g. , schizophrenia , dementia , bipolar disorder ) show past medical history prior study start Patients recent ( within last three [ 3 ] year prior study start ) and/or recurrent history autonomic dysfunction ( e.g . recurrent episode fainting , palpitation , orthostatic hypotension etc. ) . Pregnant nursing ( lactate ) woman . Baselines ( 1 2 ) . Patients history drug alcohol abuse within 12 month prior dose Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>non-chronic migraine , migraine prevention</keyword>
</DOC>